# The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

> **NCT00012506** · PHASE3 · UNKNOWN · sponsor: **National Eye Institute (NEI)**

## Conditions studied

- Uveitis
- Arthritis, Juvenile Rheumatoid

## Interventions

- **DRUG:** TNFR:Fc

## Key facts

- **NCT ID:** NCT00012506
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00012506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00012506, "The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00012506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*